3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
Etoposide
4
Vincristine
3
Rituximab
3
Prednisone
3
Doxorubicin
3
Cyclophosphamide
3
prednylidene
2
deltacortene
2
Cytarabine
2
varlilumab
1
merphos
1
ixazomib
1
carmustine, poliferprosan 20 drug combination
1
belantamab mafodotin
1
Vorinostat
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Methotrexate
1
Melphalan
1
Immunoglobulin G
1
Hydrocortisone
1
Disulfides
1
Carmustine
1
CT-P10
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Plasmablastic Lymphoma
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.